STI(SZ:300416)2015-10-23 16:00Financial Performance - Net profit attributable to shareholders was ¥8,604,110.12, reflecting a growth of 31.08% year-on-year[7]. - Total operating revenue for the period was ¥64,859,933.43, up 17.31% from the same period last year[7]. - The company's net cash flow from operating activities was negative at -¥35,812,793.63, a decline of 290.86% compared to the previous year[7]. - Basic earnings per share remained stable at ¥0.14, with no change from the previous period[7]. - The company's main business revenue reached 191.22 million yuan, an increase of 16.97% year-on-year, driven primarily by a 37.84% increase in testing service revenue to 70.99 million yuan[17]. - Other income increased by 245% year-on-year, mainly due to government subsidies received during the reporting period[18]. - The company's total operating revenue for the third quarter was CNY 45,193,184.42, an increase of 10.6% compared to CNY 41,031,892.07 in the same period last year[53]. - Year-to-date net profit was CNY 28,301,131.89, an increase of 25.5% compared to CNY 22,494,422.08 in the same period last year[57]. - The company reported a year-to-date operating profit of CNY 33,146,024.66, up from CNY 28,015,027.82, reflecting a growth of 18.5%[56]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥530,492,477.87, an increase of 21.52% compared to the previous year[7]. - The total current assets amount to 341,476,022.70, an increase from 270,592,504.21 at the beginning of the period[41]. - The total liabilities include accounts payable of 27,124,653.21, down from 40,001,282.59[42]. - The total liabilities decreased from CNY 158,108,753.59 to CNY 84,687,150.07, a reduction of 46.5%[44]. - The equity attributable to shareholders of the parent company increased to CNY 421,552,293.20 from CNY 265,701,392.65, marking a growth of 58.7%[44]. Cash Flow - Cash flow from operating activities showed a net outflow of ¥35,812,793.63, worsening from a net outflow of ¥9,162,573.88 in the previous period[64]. - Cash inflow from operating activities totaled ¥201,013,957.93, compared to ¥175,090,410.07 in the previous period, reflecting a growth of 14.8%[63]. - Investment activities resulted in a net cash outflow of ¥54,097,534.07, compared to a net outflow of ¥40,662,562.71 in the previous period[65]. - Financing activities generated a net cash inflow of ¥81,959,100.60, a substantial increase from ¥7,614,781.08 in the previous period[65]. - The net increase in cash and cash equivalents was -¥26,450,957.23, compared to -¥35,814,615.06 in the previous year[68]. Shareholder Information - The company reported a total of 7,917 shareholders at the end of the reporting period[12]. - The top shareholder, Suzhou Testing Instrument General Factory, holds 47.77% of the shares, totaling 30,000,000 shares[13]. - The company has established a five-year dividend return plan for shareholders post-listing to ensure stable returns[25]. - The company plans to ensure that the cash dividends from wholly-owned or controlled subsidiaries are no less than 20% of their distributable profits each year[24]. - The profit distribution proposal must be approved by more than half of the independent directors and the supervisory board before being submitted to the shareholders' meeting[24]. Inventory and Receivables - Inventory balance increased to ¥111,272,000, accounting for 21.29% of total assets, indicating a rising trend due to business expansion[11]. - Accounts receivable rose to ¥111,729,800, primarily due to increased revenue and extended payment cycles from clients[11]. - Inventory increased by 60.39% compared to the beginning of the year, attributed to increased order volume and expanded production scale[18]. - Accounts receivable notes decreased by 43.92% compared to the beginning of the year, mainly due to the maturity and transfer of notes for payment[18]. Investment and Expansion - The company plans to use the raised funds for projects including vibration testing equipment upgrades and laboratory network expansion, which are expected to enhance product structure and service capabilities[30]. - The expansion project has achieved a progress rate of 92.61%, with an investment of 3,641.05 million out of a total commitment of 7,500 million[35]. - The laboratory network expansion project has a progress rate of 99.88%, with an investment of 334.82 million out of a total commitment of 5,559 million[35]. Profit Distribution Policy - The company is committed to a stable profit distribution policy, prioritizing cash dividends while considering sustainable development[22]. - The company has a profit distribution policy where cash dividends should account for at least 80% of distributable profits during mature stages without major capital expenditures[23]. - The company emphasizes the importance of considering the opinions of independent directors and public investors in the profit distribution decision-making process[24]. - The cash dividend policy may be adjusted in response to significant changes in external operating conditions or the company's own situation, with shareholder protection as a priority[25].